Researcher
Hans Wildiers
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From1 Oct 2005 → Today
Projects
11 - 20 of 27
- EXPLORING AGEING-RELATED BIOMARKERS IN INDIVIDUALS WITH BREAST CANCER AND WITHOUT CANCERFrom13 Jan 2020 → 27 Jun 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Linking patient adiposity to tumour microenvironment and therapy response in breast cancer: towards tailored treatment strategies in obesityFrom27 Sep 2019 → 30 Sep 2023Funding: FWO Strategic Basic Research Grant, Foundations, funds and other with scientific goal
- Dissection of molecular determinants of metastasis and detailed characterization of the age-related immunological profile in (older) patients with hormone-sensitive breast cancerFrom1 Sep 2019 → 11 Dec 2023Funding: Foundations, funds and other with scientific goal
- Long-term outcomes in older patients with cancer and the association with geriatric screening and assessment resultsFrom18 Mar 2019 → 28 Sep 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Relapse in breast and gynaecological cancers.From1 Feb 2019 → 1 Oct 2021Funding: Private funding of national origin - undefined
- A metabolomics signature on liquid biopsy as a prognostic and predictive biomarker in early breast cancerFrom1 Jan 2019 → 31 Dec 2022Funding: Foundations, funds and other with scientific goal
- Role of combined chemo- and immunotherapy in early breast cancerFrom1 Oct 2016 → 30 Sep 2020Funding: Nonprofit institution or equivalents
- BIOMEX: a software to alleviate the bottlenecks in the analysis-to-interpretation pipeline of omics datasetsFrom27 Jun 2016 → 19 Jan 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- OPTImisation of cancer treatment in AGEd persons : integration of geriatric assessment and aging biomarker analysis in elderly clinical cancer trialsFrom1 Jan 2016 → 31 Dec 2019Funding: FWO research project (including WEAVE projects)
- DNA methylation dynamics underlying therapy resistance in cancerFrom1 Oct 2015 → 23 Jun 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 475
- Serum methylmalonic acid concentrations at breast cancer diagnosis significantly correlate with clinical frailty(2024)
Authors: Sigrid Hatse, Cindy Kenis, Anke Vandekeere, Yentl Lambrechts, François Richard, Patrick Neven, Ines Nevelsteen, Christine Desmedt, Sarah-Maria Fendt, Hans Wildiers
- Artificial intelligence electrocardiogram as a novel screening tool to detect a newly abnormal left ventricular ejection fraction after anthracycline-based cancer therapy.(2024)
Authors: Johanna Jacobs, Hans Wildiers, Rik Willems, Jens-Uwe Voigt, Lucas Van Aelst
Pages: 560 - 566 - Reporting on invasive lobular breast cancer in clinical trials: a systematic review.(2024)
Authors: Karen Van Baelen, Josephine Van Cauwenberge, Beppe Floris, Patrick Neven, Hans Wildiers, Christine Desmedt
Pages: 23 - Aging-accumulated methylmalonic acid serum levels at breast cancer diagnosis are not associated with distant metastases(2024)
Authors: Sigrid Hatse, Cindy Kenis, Anke Vandekeere, François Richard, Patrick Neven, Christine Desmedt, Sarah-Maria Fendt, Hans Wildiers
- A care pathway for older patients with multimorbidity including cancer - Design of the GERONTE pathway(2024)
Authors: Cindy Kenis, Hans Wildiers
- Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial(2024)
Authors: Hans Wildiers
Pages: 532 - 541 - Self-reported electronic symptom monitoring in older patients with multimorbidity treated for cancer: Development of a core dataset based on expert consensus, literature review, and quality of life questionnaires(2024)
Authors: Hans Wildiers, Annemarie Coolbrandt
- Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium(2024)
Authors: Hans Wildiers
Pages: 351 - 363 - Assessing patient-reported outcomes (PROs) and patient-related outcomes in randomized cancer clinical trials for older adults: Results of DATECAN-ELDERLY initiative(2024)
Authors: Hans Wildiers
- Trial watch: chemotherapy-induced immunogenic cell death in oncology(2023)
Authors: Jenny Sprooten, Isaure Vanmeerbeek, Stefan Naulaerts, Lisa Kinget, An Coosemans, Steven De Vleeschouwer, Els Wauters, Sabine Tejpar, Benoit Beuselinck, Sigrid Hatse, et al.